Solu Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- April 29, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $41,000,000
Company Info
- Company Description
- Solu Therapeutics is a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas.
- Market
- Cancer, Immunology
- Location
- Boston, MA, US
- Coinvestors
- Eli Lilly and Company, Biovision Ventures, Pappas Capital, Hengdian Group Capital, The Leukemia & Lymphoma Society Therapy Acceleration Program, Longwood Fund, DCVC Bio, Sante Ventures, Astellas Venture Management, Alexandria Venture Investments